Society of Hematologic Oncology Seventh Annual Meeting (SOHO 2019)

https://www.soho2019.com/

 

New Frontline Regimens in Peripheral T-Cell Lymphoma: Brentuximab Vedotin+CHP, Lenalidomide, Alemtuzumab and Romidepsin for CHOP/CHOP-like + Disease

October 18, 2019

0 Comments
Login to view comments. Click here to Login